MVision AI develops a guideline-based segmentation solution for radiotherapy AI contouring. The company provides a comprehensive solution that enables automation, contour comparison, and continuous education for introducing AI contouring into radiotherapy departments.

Mahmudul Hasan

Jarkko Niemelä

Saad Ullah Akram

MVision

MVision AI’s mission is to develop responsible AI tools that support and optimize efficiencies for radiotherapy departments and their clinical teams.

The AI-powered segmentation tool helps to standardize contouring and automate it to streamline the radiotherapy treatment planning workflow. 

Our deep learning models produce consistent automated contouring in minutes instead of hours of manual work, while maintaining the highest standards of quality for every patient, every time. 

MVision AI’s Contour+ has been used for treating more than 170,000 cancer patients in 16+ countries.

Nuard Ventures

Icebreaker.vc

Asko Schrey

Otto Söderlund

Voima Ventures

J12 Ventures

MVision AI

Yesterday was #NationalMedicalDosimetristsDay and we’re dedicating this entire week to honor these critical members of the radiation oncology teams!

#MedicalDosimetrists play a crucial role in developing, optimizing and monitoring treatment plans. Their expertise ensures that cancer patients receive the most effective treatment while protecting healthy organs, making a profound and significant impact on patients' lives.

As a company that innovates tirelessly to equip and empower oncology professionals with the most advanced tools, we celebrate and honor all medical dosimetrists around the world!

To all #MedicalDosimetrists our words reach, we deeply appreciate the dedication and skill you bring to cancer care! Thank you for everything you do!

#EmpoweringHeroes #CancerCare #RadOnc

Last week, the team MVision AI united at MVision AI HQ in Helsinki, coming together from all corners of the globe—not just to work, but to connect, challenge each other and grow stronger as one! From solving puzzles on a mysterious island to strategizing in laser tag and enjoying a well-deserved cruise, every moment reminded us why our team is so special.

We’re not just pushing the boundaries of innovation and advancements in cancer care; we’re also making a real impact in each other’s lives. It’s the brilliant minds and kind hearts at MVision AI that make this journey so incredible.

To all our #MVisionaries: You inspire, you innovate and you make a difference! Let’s keep pushing forward, stronger and more united than ever! 

#MVisionAI #BeyondBoundaries #GoTeam

MVision AI is coming soon to Washington, DC, and we can’t wait to introduce you to our revolutionary GBS™ solution at #ASTRO2024!

What is #GBS™?
GBS™ is an all-in-one solution designed to enhance accuracy and achieve standardization in radiotherapy treatment planning workflows. It includes:
#Contour+: AI-powered automation for efficient, guideline-compliant contouring.
#Guide: A comprehensive training platform designed to enhance contouring skills and ensure adherence to current guidelines.
#Verify: A robust contour assessment tool that builds trust in AI by comparing contours against benchmarks.

Stay tuned for more updates as we get ready to showcase how GBS™ can transform your radiotherapy workflow. See you at #ASTRO24!

#MvisionAI #GBS #AIInRadiotherapy #Innovation

MVision AI has just received Central Drugs Standard Control Organization (CDSCO) approval for #Contour+ in India. This milestone marks a huge leap forward in revolutionizing cancer care across the country.

#Contour+ is designed to streamline the contouring process, enhance consistency and save valuable time for radiation therapy departments. This means more efficient workflows and improved patient care, which is crucial as cancer rates continue to rise in India.

Our revalutionary AI-powered solution #GBS™, consisting of Contour+, Guide, and Verify, is set to drive new standards in radiation oncology, ensuring that professionals have the tools they need for precise and timely care.

We’re excited about this new chapter and committed to supporting oncology teams in India with our cutting-edge solutions. 

For more details on how #Contour+ can make a difference in your practice, check out: https://lnkd.in/eeMZeJ4h

To read the press release: https://lnkd.in/d3ZDjY3p

Thanks to everyone who contributed to this success!

#AI #CancerCare #News

We're #hiring a new Events and Marketing Communications Intern in Helsinki, Uusimaa. Apply today or share this post with your network.

As #AAPM2024 comes to a close, a big thank you to all the incredible professionals we had the pleasure of meeting! We’re filled with pride for what we’ve achieved together and excitement for what we will accomplish ahead!

As we do after each event, we’re heading home more motivated than ever about our mission—with the power of AI, empowering radiation oncology professionals so they can deliver the best quality of care for their patients.

Thank you once again for making this event unforgettable and we look forward to seeing you all again at #AAPM2025 in Washington, DC!

#AAPM #CancerCare 

https://mvision.ai/

Day 3 at #AAPM2024! A huge thank you to everyone who visited our booth yesterday! It was great to reconnect with old friends and meet so many new faces. Your reactions and feedback about our solutions truly made our day!
If you missed us yesterday, no worries! Today is your chance to see our technology in action. Come by booth #1115 from 9:00 am to 5:00 pm to discover how MVision AI can revolutionize your clinic and practice.

We can’t wait to see you and share more about what makes our AI-powered guideline-based segmentation solution #GBS™ groundbreaking!

#AAPM24 #AIInCancerCare #CancerCare

https://mvision.ai/

Hello from sunny Los Angeles! We kicked off #AAPM2024 yesterday and it was truly humbling to welcome so many visitors, customers and partners to our booth. Today marks the second day and we're excited to continue the momentum!

If you're at the LA Convention Center today, stop by booth #1115. We've got some exciting news to share and can't wait to connect with you! Plus, grab one of our MVision-blue stress balls to take home!

Here's to another great day at #AAPM2024!

#AAPM #AAPM24 #CancerCare #AIinCancerCare #RadiationTherapy

The countdown has begun! Just a few days left until #AAPM2024! From July 21-24, meet us at booth #1115 at the Los Angeles Convention Center. We can't wait to tell you more about our new innovations.

You can secure your demo session now: https://lnkd.in/d9g2Nbz9

Or reach out to our team to find the best time to meet us:
Dharanipathy Rangaraj PhD, MBA, CEO
Mahmudul Hasan, Founder & Executive Director
Gregory Brown, VP of North America Sales
Gregory Bolard, Clinical Scientist
Yaspal Badyal PhD DABR, VP of Growth and Innovation
Hayden Rapp, Inside Sales and Marketing North America

Have a safe journey on your way to Los Angeles and see you soon! We'll be sharing more updates from the site, so stay tuned!

https://mvision.ai/

#AAPM #CancerCare #AIinCancerCare #RadiationTherapy

We're #hiring a new Clinical Success Specialist in Helsinki, Uusimaa. 
Apply today or share this post with your network.

Metric
Company Name	MVision
Symbol
MSH ID	AI:MVISION
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Technology
Country	FI
Stage
Employee Count	11
Website	mvision.ai
LinkedIn	mvisionai
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AI:MVISION

MVision

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue